Two signals (Ag and costimulation) are required to activate naive CD8 T cells, but they are not sufficient. Work done during the previous granting period has provided strong evidence that the cells need a third signal in order to undergo clonal expansion and develop effector function and a responsive memory population. Signal three can be provided by IL-12 or Type I IFNs, as demonstrated by in vitro activation, and in vivo by their ability to replace the need for adjuvant in stimulating a response to peptide Ag. Thus, the third signal converts a tolerizing exposure to Ag to effective priming.
The aims to be pursued include:
Aim 1. To determine if IL-12 and IFN-alpha provide the third signal for naive CD8 T cell activation by dendritic cells and by in vivo challenge with Ag. Experiments will be done to determine if stimulation by activated DC requires IL-12 and/or IFN-alpha, and whether CD40-dependent help from CD4 cells involves stimulation of DC to produce signal 3 cytokines. In vivo experiments will employ cytokine- and receptor-deficient mice to determine the extent to which CTL responses depend upon IL-12 and/or Type I IFNs.
Aim 2. To determine the effects of signal 3 cytokines on activation of naive CD8 T cells: gene regulation, survival and effector function. Functional studies and gene array analyses have suggested a number of hypotheses regarding mechanisms by which signal three contributes to activation, and these will be tested.
Aim 3. To determine expression in memory cells of genes regulated in naive cells by signal 3 cytokines. Memory cells do not require a third signal to be activated, and the basis for this will be determined. It is anticipated that the results of these studies will contribute novel insights into the requirements for generatingCD8 T cell responses. In addition, the results will have important implications for manipulating these responses for protective and therapeutic immunizations, and potentially for induction of tolerance where it is desirable that responses be prevented.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI034824-15
Application #
7369895
Study Section
Experimental Immunology Study Section (EI)
Program Officer
Mallia, Conrad M
Project Start
1993-07-01
Project End
2009-07-05
Budget Start
2008-03-01
Budget End
2009-07-05
Support Year
15
Fiscal Year
2008
Total Cost
$271,447
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Pathology
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Gerner, Michael Y; Heltemes-Harris, Lynn M; Fife, Brian T et al. (2013) Cutting edge: IL-12 and type I IFN differentially program CD8 T cells for programmed death 1 re-expression levels and tumor control. J Immunol 191:1011-5
Curtsinger, Julie M; Agarwal, Pujya; Lins, Debra C et al. (2012) Autocrine IFN-ýý promotes naive CD8 T cell differentiation and synergizes with IFN-ýý to stimulate strong function. J Immunol 189:659-68
Curtsinger, Julie M; Mescher, Matthew F (2010) Inflammatory cytokines as a third signal for T cell activation. Curr Opin Immunol 22:333-40
Gerner, Michael Y; Mescher, Matthew F (2009) Antigen processing and MHC-II presentation by dermal and tumor-infiltrating dendritic cells. J Immunol 182:2726-37
Agarwal, Pujya; Raghavan, Arvind; Nandiwada, Sarada L et al. (2009) Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J Immunol 183:1695-704
Xiao, Zhengguo; Casey, Kerry A; Jameson, Stephen C et al. (2009) Programming for CD8 T cell memory development requires IL-12 or type I IFN. J Immunol 182:2786-94
Hammerbeck, Christopher D; Mescher, Matthew F (2008) Antigen controls IL-7R alpha expression levels on CD8 T cells during full activation or tolerance induction. J Immunol 180:2107-16
Gerner, Michael Y; Casey, Kerry A; Mescher, Matthew F (2008) Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses. J Immunol 181:155-64
Mescher, Matthew F; Agarwal, Pujya; Casey, Kerry A et al. (2007) Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation. Semin Immunol 19:153-61
Xiao, Zhengguo; Mescher, Matthew F; Jameson, Stephen C (2007) Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation. J Exp Med 204:2667-77

Showing the most recent 10 out of 36 publications